Natdac 60 Tablet (Daclatasvir 60mg)

What is Natdac 60 Tablet (Daclatasvir 60mg)?

Natdac 60 Tablet contains daclatasvir 60mg, an antiviral medication used to treat chronic hepatitis C virus (HCV) infection. It works by inhibiting the NS5A protein, which is essential for viral replication, thereby reducing the amount of virus in the body. Natdac is typically prescribed as part of a combination therapy, often with sofosbuvir, for treating HCV genotypes 1 and 3. It is not a cure on its own but significantly improves sustained virologic response rates when used correctly under a healthcare provider's guidance.

Key features

• Active Ingredient — Daclatasvir 60mg per tablet.
• Antiviral Class — NS5A inhibitor targeting hepatitis C replication.
• Prescription Required — Must be used under medical supervision.
• Combination Therapy — Designed to be used with other antivirals like sofosbuvir.
• Genotype Coverage — Effective against HCV genotypes 1 and 3.
• Oral Administration — Taken once daily with or without food.
• Manufactured for Global Use — Sourced for international markets with consistent quality standards.

Who is Natdac 60 Tablet (Daclatasvir 60mg) for?

This medication is intended for adults diagnosed with chronic hepatitis C, particularly genotypes 1 and 3. It is suitable for patients without cirrhosis or with compensated liver disease. It is not recommended for children or individuals with severe liver impairment unless directed by a specialist. Patients must consult a physician before starting treatment to ensure proper diagnosis and drug compatibility.

How does Natdac 60 Tablet (Daclatasvir 60mg) compare?

Compared to standard polypropylene rugs or fixed overhead cranes, Natdac 60 Tablet serves a completely different medical purpose. Unlike general wellness supplements, it is a targeted antiviral therapy requiring prescription use. It offers a more specific mechanism of action than older interferon-based treatments, with fewer side effects and higher cure rates. While similar in function to other NS5A inhibitors, it is often more affordable than branded alternatives, making it a cost-effective option in global markets.